Replies to post #11806 on Moderna Inc (MRNA)

[axelvento]

In a report released today, Leah R. Cann from Brookline Capital Markets maintained a Buy rating on Moderna (MRNA – Research Report), with a price target of $506.00

https://www.tipranks.com/news/blurbs/moderna-mrna-gets-a-buy-rating-from-brookline-capital-markets?utm_source=advfn.com&utm_medium=referral